Cholangiocarcinoma of the Gallbladder Recruiting Phase 2 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0029558 (Cholangiocarcinoma of the Gallbladder)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03043547Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based TherapiesTreatment